文献速递脑血管病头痛与眩晕

特发性颅内高压与英国女性心血管疾病风险的关联

Association Between Idiopathic Intracranial Hypertension and Risk of Cardiovascular Diseases in Women in the United Kingdom.
PubMed 文献 · JAMA Neurol · 2019-01-01

结果显示IIH女性复合心血管事件风险约为对照的2倍,心衰、缺血性心脏病、卒中/短暂性脑缺血发作(TIA)、2型糖尿病及高血压风险均升高,且2005至2017年女性IIH发病率增长超过三倍。

要点

  • IIH女性复合心血管事件风险升高约2倍(aHR 2.10)。
  • 心衰、缺血性心脏病及卒中/TIA风险均约升高2倍。
  • 2005至2017年女性IIH发病率由2.5升至9.3/10万人年。

核心结论

  • 女性特发性颅内高压与心血管疾病风险约2倍升高相关,改变患者管理以干预心血管危险因素或可降低长期疾病负担,仍需进一步评估。

研究设计与样本

  • 基于英国THIN电子病历数据库的人群匹配对照队列研究,使用1990年1月1日至2018年1月17日共28年数据。
  • 采用Cox回归模型计算心血管结局的校正风险比(aHR)。

主要发现

  • 暴露组中位年龄32.1(25.6-42.0)岁,1728例(62.6%)肥胖;对照组中位年龄32.1(25.7-42.1)岁,16514例(60.9%)肥胖。
  • 复合心血管事件aHR 2.10(95%CI 1.61-2.74;P<.001),心衰aHR 1.97(95%CI 1.16-3.37;P=.01)。
  • 缺血性心脏病aHR 1.94(95%CI 1.27-2.94;P=.002),卒中/TIA aHR 2.27(95%CI 1.61-3.21;P<.001)。
  • 2型糖尿病aHR 1.30(95%CI 1.07-1.57;P=.009),高血压aHR 1.55(95%CI 1.30-1.84;P<.001)。
  • 2005至2017年女性IIH发病率由2.5升至9.3/10万人年,患病率由26升至79/10万女性,发病率随BMI超过30明显升高。

临床怎么用

  • 对IIH女性患者应关注并管理心血管危险因素,如体重、血压、血糖和血脂,以降低长期心血管疾病负担。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Cardiovascular disease (CVD) risk has not been previously evaluated in a large matched cohort study in idiopathic intracranial hypertension (IIH). OBJECTIVES: To estimate the risk of composite cardiovascular events, heart failure, ischemic heart disease, stroke/transient ischemic attack (TIA), type 2 diabetes, and hypertension in women with idiopathic intracranial hypertension and compare it with the risk in women, matched on body mass index (BMI) and age, without the condition; and to evaluate the prevalence and incidence of IIH. DESIGN, SETTING, AND PARTICIPANTS: This population-based matched controlled cohort study used 28 years of data, from January 1, 1990, to January 17, 2018, from The Health Improvement Network (THIN), an anonymized, nationally representative electronic medical records database in the United Kingdom. All female patients aged 16 years or older were eligible for inclusion. Female patients with IIH (n = 2760) were included and randomly matched with up to 10 control patients (n = 27 125) by BMI and age. MAIN OUTCOMES AND MEASURES: Adjusted hazard ratios (aHRs) of cardiovascular outcomes were calculated using Cox regression models. The primary outcome was a composite of any CVD (heart failure, ischemic heart disease, and stroke/TIA), and the secondary outcomes were each CVD outcome, type 2 diabetes, and hypertension. RESULTS: In total, 2760 women with IIH and 27 125 women without IIH were included. Age and BMI were similar between the 2 groups, with a median (interquartile range) age of 32.1 (25.6-42.0) years in the exposed group and 32.1 (25.7-42.1) years in the control group; in the exposed group 1728 women (62.6%) were obese, and in the control group 16514 women (60.9%) were obese. Higher absolute risks for all cardiovascular outcomes were observed in women with IIH compared with control patients. The aHRs were as follows: composite cardiovascular events, 2.10 (95% CI, 1.61-2.74; P < .001); heart failure, 1.97 (95% CI, 1.16-3.37; P = .01); ischemic heart disease, 1.94 (95% CI, 1.27-2.94; P = .002); stroke/TIA, 2.27 (95% CI, 1.61-3.21; P < .001); type 2 diabetes, 1.30 (95% CI, 1.07-1.57; P = .009); and hypertension, 1.55 (95% CI, 1.30-1.84; P < .001). The incidence of IIH in female patients more than tripled between 2005 and 2017, from 2.5 to 9.3 per 100 000 person-years. Similarly, IIH prevalence increased in the same period, from 26 to 79 per 100 000 women. Incidence increased markedly with BMI higher than 30. CONCLUSIONS AND RELEVANCE: Idiopathic intracranial hypertension in women appeared to be associated with a 2-fold increase in CVD risk; change in patient care to modify risk factors for CVD may reduce long-term morbidity for women with IIH and warrants further evaluation.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Adderley NJ, Subramanian A, Nirantharakumar K, et al. Association Between Idiopathic Intracranial Hypertension and Risk of Cardiovascular Diseases in Women in the United Kingdom. JAMA Neurol. 2019. PMID: 31282950. doi:10.1001/jamaneurol.2019.1812

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。